Polynovo Ltd

PNV: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|gh??^gLOCK|>mLOCK|h#J^d%f

Polynovo: Immaterial Impact Expected From Reimbursement Changes for Outpatients

The Centers for Medicare & Medicaid Services aims to save money by proposing to reimburse United States clinicians a flat fee for outpatient skin substitutes from Jan. 1, 2026, rather than a percentage of the product price. A decision is expected in November. Shares in Polynovo are up 7%.

Sponsor Center